Skip to main content

Compagnie Lombard Odier SCmA

Position in NVO — Novo Nordisk A S

CIK 1615423 1204 GENEVA, V8

Position in NVO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$960,190
+$196,525 QoQ
Shares Held
20,029
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#534
of 1,348 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Compagnie Lombard Odier SCmA holds $723,906,825 across 10 Drug Manufacturers - General names. NVO ranks #8 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
20,029 $960,190

All Filings in NVO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $960,190 20,029
2026-03-31 $763,665 20,780
2025-12-31 $2,297,740 45,160
2025-09-30 $2,543,383 45,835
2025-06-30 $3,525,886 51,085
2025-03-31 $4,390,690 63,230
2024-12-31 $5,827,424 67,745
2024-09-30 $7,685,372 64,545
2024-06-30 $9,098,960 63,745
2024-03-31 $8,195,772 63,830
2023-12-31 $5,852,683 56,575
2023-09-30 $4,356,935 47,910
2023-06-30 $3,763,356 23,255
2023-03-31 $1,949,465 12,250
2022-12-31 $779,423 5,759
2022-09-30 $633,547 6,359